Will BioLine RX Ltd - ADR (BLRX) Stay at the Top of the Healthcare Sector?

A rating of 97 puts BioLine RX Ltd - ADR (BLRX) near the top of the Healthcare sector according to InvestorsObserver. BioLine RX Ltd - ADR's score of 97 means that it ranks higher than 97% of stocks in the sector. In addition, its overall score of 56 ranks it higher than 56% of all stocks.

BLRX has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on BLRX!

See Full BLRX Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 56 would rank higher than 56 percent of all stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With BioLine RX Ltd - ADR Stock Today?

BioLine RX Ltd - ADR (BLRX) stock has fallen -5.08% while the S&P 500 has risen 0.73% as of 10:04 AM on Friday, Sep 29. BLRX is lower by -$0.10 from the previous closing price of $1.97 on volume of 96,292 shares. Over the past year the S&P 500 has gained 18.97% while BLRX has risen 107.78%. BLRX lost -$0.73 per share the over the last 12 months. Click Here to get the full Stock Report for BioLine RX Ltd - ADR stock.